Kristufek Doris, Rudorfer Walter, Pifl Christian, Huck Sigismund
Brain Research Institute, University of Vienna, Spitalgasse 4, A-1090 Vienna, Austria.
J Physiol. 2002 Aug 15;543(Pt 1):117-34. doi: 10.1113/jphysiol.2002.021170.
Reuptake of extracellular noradrenaline (NA) into superior cervical ganglion (SCG) neurones is mediated by means of the noradrenaline transporter (NAT, uptake 1). We now demonstrate by single-cell RT-PCR that mRNA of the organic cation transporter 3 (OCT3, uptake 2) occurs in rat SCG neurones as well. Furthermore, our RT-PCR analyses reveal the presence of mRNA for novel organic cation transporters 1 and 2 (OCTN1 and OCTN2), but not for OCT1 or OCT2 in the ganglion. Making use of the NAT as a powerful, neurone-specific transporter system, we loaded[3H]-N-methyl-4-phenylpyridinium ([3H]-MPP+) into cultured rat SCG neurones. The ensuing radioactive outflow from these cultures was enhanced by desipramine and reserpine, but reduced (in the presence of desipramine) by the OCT3 inhibitors cyanine 863, oestradiol and corticosterone. In contrast, cyanine 863 enhanced the radioactive outflow from cultures preloaded with [3H]-NA. Two observations suggest that a depletion of storage vesicles by cyanine 863 accounts for the latter phenomenon: first, the primary radioactive product isolated from supernatants of cultures loaded with [3H]-NA was the metabolite [3H]-DHPG; and second, inhibition of MAO significantly reduced the radioactive outflow in response to cyanine 863. The outflow of [3H]-MPP+ was significantly enhanced by MPP+, guanidine, choline and amantadine as potential substrates for OCT-related transmembrane transporters. However, desipramine at a low concentration essentially blocked the radioactive outflow induced by all of these substances with the exception of MPP+, indicating the NAT and not an OCT as their primary site of action. The MPP+-induced release of [3H]-MPP+ was fully prevented by a combined application of desipramine and cyanine 863. No trans-stimulation of [3H]-MPP+ outflow was observed by the OCTN1 and OCTN2 substrate carnitine at 100 microM. Our observations indicate an OCT-mediated transmembrane transport of [3H]-MPP+. Amongst the three OCTs expressed in the SCG, OCT3 best fits the profile of substrates and antagonists that cause trans-stimulation and trans-inhibition, respectively, of [3H]-MPP+ release.
细胞外去甲肾上腺素(NA)被摄取进入颈上神经节(SCG)神经元是通过去甲肾上腺素转运体(NAT,摄取1)介导的。我们现在通过单细胞逆转录聚合酶链反应(RT-PCR)证明,有机阳离子转运体3(OCT3,摄取2)的信使核糖核酸(mRNA)也存在于大鼠SCG神经元中。此外,我们的RT-PCR分析揭示了神经节中存在新型有机阳离子转运体1和2(OCTN1和OCTN2)的mRNA,但不存在OCT1或OCT2的mRNA。利用NAT作为一种强大的、神经元特异性的转运体系统,我们将[3H]-N-甲基-4-苯基吡啶鎓([3H]-MPP+)载入培养的大鼠SCG神经元中。这些培养物随后的放射性流出被地昔帕明和利血平增强,但(在地昔帕明存在的情况下)被OCT3抑制剂花青863、雌二醇和皮质酮减少。相反,花青863增强了预先载入[3H]-NA的培养物的放射性流出。两项观察结果表明,花青863导致储存囊泡耗竭是造成后一种现象的原因:第一,从载入[3H]-NA的培养物上清液中分离出的主要放射性产物是代谢物[3H]-DHPG;第二,单胺氧化酶(MAO)的抑制显著减少了对花青863的放射性流出反应。作为OCT相关跨膜转运体的潜在底物,MPP+、胍、胆碱和金刚烷胺显著增强了[3H]-MPP+的流出。然而,低浓度的地昔帕明基本上阻断了除MPP+之外所有这些物质诱导的放射性流出,表明NAT而非OCT是它们的主要作用位点。地昔帕明和花青863联合应用完全阻止了MPP+诱导的[3H]-MPP+释放。在100微摩尔浓度下,OCTN1和OCTN2的底物肉碱未观察到对[3H]-MPP+流出的跨刺激作用。我们的观察结果表明存在OCT介导的[3H]-MPP+跨膜转运。在SCG中表达的三种OCT中,OCT3最符合分别引起[3H]-MPP+释放的跨刺激和跨抑制的底物和拮抗剂的特征。